The Annual PHARM Connect Congress for Enlarged Europe is one of the largest pharmaceutical and biotechnology manufacturing events in Central and Eastern Europe and the CIS market in 2013. The event is bringing together around 500 senior decision-makers from Europe’s leading pharmaceutical and biotechnology companies, giving them the opportunity to share their knowledge and discuss their key priorities.
The Annual PHARM Connect Congress for Enlarged Europe is one of the largest pharmaceutical and biotechnology manufacturing events in Central and Eastern Europe and the CIS market in 2013.
The event is bringing together around 500 senior decision-makers from Europe’s leading pharmaceutical and biotechnology companies, giving them the opportunity to share their knowledge and discuss their key priorities.
Most up-to-date market insightsPHARM Connect is supported by numerous leading local and regional media partners and associations, an exposure which ensures the regional focus of the congress. Furthermore, the Programme Advisory Committee assures the highest relevance of the conference programme, which will include the most up-to-date market insights into R&D, Production, Packaging, Logistics, Supply Chain and Quality Management-related topics.
Pre-scheduled business meetings
Moreover, it is the perfect setting for local and international solution-providers to present their products and services directly to key decision-makers. Each solution-provider is selected based on requirements and interests stated by attending professionals prior to the event.
Several weeks in advance of the congress the TEG Meeting Scheduler is made available to every solution-provider and delegate attending. On the site they are able to select key presentations, pre-schedule one-to-one meetings and confirm their presence at several additional networking activities, giving them the opportunity to create their own itinerary prior to the congress taking place.
Additional networking activities
Furthermore, additional networking activities such as seated buffet luncheons or the
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.